About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Biomarker Predicts Effectiveness of Brain Cancer Treatment: Study

by Sheela Philomena on July 2, 2014 at 11:28 AM
Font : A-A+

 Biomarker Predicts Effectiveness of Brain Cancer Treatment: Study

A new biomarker that predicts whether glioblastoma will respond to chemotherapy has been discovered by scientists. The findings are published in the July print issue of Oncotarget.

"Every patient diagnosed with glioblastoma is treated with a chemotherapy called temozolomide. About 15 percent of these patients derive long-lasting benefit," said Clark C. Chen, MD, PhD, vice-chairman of Academic Affairs, Division of Neurosurgery, UC San Diego School of Medicine and the study's principal investigator. "We need to identify which patients benefit from temozolomide and which another type of treatment. All therapies involve risk and the possibility of side-effects. Patients should not undergo therapies if there's no likelihood of benefit."

Advertisement

To pinpoint which patients were most likely respond to temozolomide, the researchers studied microRNAs that control the expression of a protein called methyl-guanine-methyl-transferase or MGMT. This protein dampens the cancer-killing effect of temozolomide. Tumors with high levels of MGMT are associated with a poor response to temozolomide therapy.

The scientists systematically tested every microRNA in the human genome to identify those that suppressed MGMT expression, with the expectation that high-levels of these microRNAs in the tumor would predict improved therapeutic response to temozolomide.
Advertisement

"We showed that a signature of the MGMT-regulating microRNAs predicted temozolomide response in a cohort of glioblastoma patients. Validation of these results should lead to diagnostic tools to enable us to determine which patients will benefit most from temozolomide therapy," said Chen.

In the study, the scientists also discovered that injection of the MGMT-regulating microRNAs into glioblastoma cells increased tumor sensitivity to temozolomide treatment.

"These findings establish the foundation for microRNAs-based therapies to increase the efficacy of temozolomide in glioblastoma patients," said lead author, Valya Ramakrishnan, PhD, postdoctoral researcher, UC San Diego School of Medicine.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Cancer and Homeopathy Parkinsons Disease Surgical Treatment Cancer Facts Cancer Tattoos A Body Art Brain Brain Facts Ataxia Cell Phone Radiation and Cancer - Unveiling the Link 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) Selfie Addiction Calculator Nutam (400mg) (Piracetam) Turmeric Powder - Health Benefits, Uses & Side Effects Blood Pressure Calculator Post-Nasal Drip Find a Hospital Drug Interaction Checker Calculate Ideal Weight for Infants Find a Doctor
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use